Modulation of Immunity by Antiangiogenic Molecules in Cancer

In the last decades a new class of therapeutic drugs have been developed that block tumor angiogenesis. These antiangiogenic molecules, which target VEGF or VEGFR, PDGFR, and c-kit, can act not only on endothelial cells but also on immune cells. Some antiangiogenic molecules inhibit the development...

Descripción completa

Detalles Bibliográficos
Autores principales: Terme, Magali, Colussi, Orianne, Marcheteau, Elie, Tanchot, Corinne, Tartour, Eric, Taieb, Julien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3540780/
https://www.ncbi.nlm.nih.gov/pubmed/23320019
http://dx.doi.org/10.1155/2012/492920

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3540780/
https://www.ncbi.nlm.nih.gov/pubmed/23320019
http://dx.doi.org/10.1155/2012/492920

Ejemplares similares